Skip to content

HON

S&P 500
Weak · 39/100

Honeywell

Industrials
Industrial Conglomerates

$228.11

0.4%

Updated Today 7:15 PM ET

Price — Past Year

▲ Up 9.5% over the last 12 months

Price 50-day average 200-day averageSource: Yahoo Finance · refreshed daily
Key Metrics

Market Cap

$145.11B

P/E

31.88x

Forward P/E (est.)

39.34x

ROE

29.1%

Revenue Growth

3.6%

EPS Growth

-19.0%

Profit Margin

11.4%

FCF Yield

4.3%

Debt / Equity

2.24x

ROIC

14.0%

Interest Coverage

Current Ratio

1.39x

Dividend Yield

2.1%

Implied Growth (rev. DCF)

5.1%

Rating Score

39/100

Technical Analysis (Educational)
Research

Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what HON's chart says today, with each tool explained.

Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. HON trades near $228.11, above its 50-day average ($221.95) and 200-day average ($213.41). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.

Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 43 it is in neutral territory — neither stretched nor washed out.

MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.

Volatility — ATR. Average True Range is the typical daily move. HON's is $7.97 (~3.5% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.

Support & resistance. Over the last month HON found buyers near $205.52 (support) and sellers near $239.94 (resistance); its 52-week range is $186.76–$248.18. A decisive break beyond either edge often marks the next move.

Volume. The latest session traded 1.2× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.

Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.

Business Overview
Research

Honeywell (HON) is a large-cap company in the Industrial Conglomerates industry, part of the Industrials sector of the S&P 500, with a market value around $145.11B.

In its latest reported year it generated about $37.44B in revenue and $4.73B in net profit.

Our model rates HON Weak (39/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Revenue Growth
Research

4Y CAGR

2.1%

Revenue moved from $34.39B in 2021 to $37.44B in 2025, a 2.1% compound annual growth rate. The most recent year was roughly flat (3.6%) year over year. Slower, mature growth is common for established businesses.

Profitability
Research

Gross Margin

36.8%

Operating Margin

21.7%

Net Margin

12.6%

ROE

29.1%

Honeywell keeps about 11.4% of each sales dollar as net profit, with a 36.8% gross margin and 21.7% operating margin. Return on equity is 29.1% and return on invested capital about 14.0%. Margins are moderate — typical of a competitive but profitable business.

Debt Analysis
Research

Total Debt

$32.11B

Net Debt

$20.13B

Net Debt / EBITDA

2.48x

Debt / Equity

2.24x

Leverage: debt-to-equity is 2.2x, with a current ratio of 1.4x. That is elevated leverage, which raises risk if earnings or rates move against it. It carries roughly $32.11B of total debt against $11.98B of cash.

Cash Flow Analysis
Research

Operating CF

$6.41B

Free Cash Flow

$5.42B

FCF Margin

14.5%

In the latest year Honeywell produced about $6.41B of operating cash flow and $5.42B of free cash flow after capital spending. That is a free-cash-flow yield of about 4.3% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.

Valuation Analysis
Research

P/E

31.88x

P/S

3.85x

P/B

8.01x

EV / EBITDA

17.4x

HON trades at 31.9x trailing earnings (about 39.3x on estimated forward earnings), 3.8x sales, and 8.0x book value. Reverse-engineering today's price implies the market expects roughly 5.1% long-term free-cash-flow growth. That is a premium multiple that needs growth to justify it.

Metrics vs. Typical Range

Where this stock sits versus what most companies trade at.

TTM P/E
31.9xExpensive
Forward P/E
39.3xExpensive
P/S ratio
3.8xExpensive
Revenue growth
3.6%Weak
EPS growth
-19.0%Weak
Gross margin
36.8%Weak
Net margin
11.4%Strong
ROE
29.1%Strong

Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.

Sector Peer Comparison

How HON stacks up against its Industrials peers — valuation, profitability, and growth versus the sector median.

In the Industrials sector (80 S&P 500 companies), HON ranks #66 of 80 by our overall rating. It trades at roughly in line versus the sector on earnings (31.9x P/E vs. 30x median) with a higher return on equity (29.1% vs. 24.7%) and slower revenue growth (3.6% vs. 5.0%).

P/E vs sector

31.9x

median 30x

ROE vs sector

29.1%

median 24.7%

Growth vs sector

3.6%

median 5.0%

Sector rank

#66

of 80 by rating

CompanyP/ERev Gr.Rating
HONThis stock31.9x3.6%Weak· 39
MMM30x2.1%Weak· 33
UBER16.1x18.3%Favorable· 62
UNP20.5x1.9%Favorable· 63
DE33.4x4.0%Weak· 37
ETN41.5x-15.1%Weak· 38
PH34.5x6.0%Neutral· 52
BA77.1x32.8%Weak· 38
Industrials median30x5.0%52/100

Valuation vs. quality map

sector medianMMMUBERUNPDEETNPHBAHONP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Industrials companies by sub-industry and size. Sector median is across all 80 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$177.57$299.07

vs. $228.11 today · expected CAGR -5%6%

Metric20262027202820292030
Revenue$38.94B$40.50B$42.12B$43.80B$45.55B
Net income$5.06B$5.26B$5.48B$5.69B$5.92B
EPS$7.99$8.31$8.64$8.99$9.35
Share price (low)$151.79$157.86$164.17$170.74$177.57
Share price (high)$255.64$265.87$276.50$287.56$299.07
CAGR (low–high)-33% / 12%-17% / 8%-10% / 7%-7% / 6%-5% / 6%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for HON:

  • Strong return on equity (29.1%) shows capital is put to work well.
  • Healthy free-cash-flow yield (~4.3%) funds buybacks and dividends.
  • Pays a 2.1% dividend on top of any price gains.
Bear Case

The case against HON:

  • Elevated leverage (debt/equity 2.2x) adds financial risk.
  • Our model's overall read is Weak (39/100).
Key Risks
Research

Valuation risk — at 31.9x earnings, disappointing results could compress the multiple.

Balance-sheet risk — debt/equity of 2.2x magnifies the impact of higher rates or weaker earnings.

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the fundamentals screen weakly: Honeywell is a large-cap industrials business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at 31.9x earnings, which our model scores Weak (39/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.